Lasofoxifene for ER-Positive Metastatic Breast Cancer Lasofoxifene for ER-Positive Metastatic Breast Cancer

Should lasofoxifene be considered as a potential treatment for ER-positive metastatic breast cancer that is resistant to endocrine therapy?Breast Cancer Research
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news